ABVC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ABVC Biopharma Inc is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows a bearish technical trend, lacks significant positive catalysts, and has no clear trading signals. While the company has shown strong revenue growth in the latest quarter, its financials remain negative, and there is no recent news or influential trading activity to support a buy decision.
The technical indicators for ABVC are bearish. The MACD histogram is negative and contracting, RSI is neutral at 30.004, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 1.588, with resistance at 2.024. Overall, the price trend is weak, and no clear reversal signals are present.
The company reported strong revenue growth in Q3 2025, with a 104.47% YoY increase. Gross margin also improved slightly to 100%.
The stock has a bearish technical setup, no recent news or significant trading activity, and lacks positive sentiment from hedge funds or insiders. Additionally, the company remains unprofitable, with a net income of -$1,246,513 in Q3 2025.
In Q3 2025, ABVC reported revenue growth of 104.47% YoY to $795,950. However, the company remains unprofitable, with a net income of -$1,246,513 (up 215.76% YoY). EPS improved to -0.05, up 66.67% YoY, and gross margin increased slightly to 100%.
No recent analyst ratings or price target changes are available for ABVC.
